Renal medicine
Dialysis CoPilot
Surface the modifiable physiology behind mortality and admission risk across a dialysis unit.
- Vascular access failure
- Fluid overload mitigation
- Intradialytic hypotension
Decision support that shows you what to change, not just what will happen. Counterfactual clinical AI for high-stakes nephrology, neurovascular, and interventional decisions.
01
Working module
09
Dialysis pathways
03
Modules in pipeline
Constructed patient data for demonstration only. Outputs are simulated projections, not clinical recommendations.
Dialysis counterfactual workspace
Working prototype · In-centre haemodialysis
KUV-HD-0482
64y · Type 2 diabetes · 4.2y on HD
Primary risk signal
Mortality, admission and haemodynamic stability
Change any assumption. The projected outcomes and mediated pathway update together.
Patient risk trajectory
Baseline mortality, counterfactual mortality and admission risk over time
Physiological pathway cascade
Mediated effects under the selected counterfactual
Systemic inflammation
Endothelial shear
Myocardial stunning
Cardiac event risk
The premise
“A risk score that cannot be acted on is just anxiety with a number attached.”
Traditional predictive ML
The confounding trap
The sickest get the strongest treatment. A model may learn that treatment predicts harm, not that it prevents it.
Feedback loops
Outcomes reflect old practice. When care changes, improvement can look like model failure.
Kuviyam causal AI
Read the trajectory
Labs, sessions, medications and events over time—not one convenient snapshot.
Route through physiology
Explicit mechanisms with named drivers, thresholds and uncertainty.
Test the change
Rank interventions by the risk they may remove for this patient.
Dialysis first · Specialty pipeline
Dialysis CoPilot is the active working prototype. Stroke, liver and renal cancer modules remain in the clinical development pipeline.
Renal medicine
Surface the modifiable physiology behind mortality and admission risk across a dialysis unit.

Neurovascular
Make time, tissue and haemorrhage trade-offs visible while the treatment window is still open.
Clinical development pipeline

Interventional radiology
Test HCC ablation and embolisation choices against functional liver reserve before treatment.
Clinical development pipeline

Interventional oncology
Balance biopsy, ablation margin and nephron protection for small renal masses.
Clinical development pipeline
Evidence & governance
The pathway map is a clinical document: reviewable, versioned and open to challenge. Every number shown here comes from constructed test cases—not real patients.
Test against defined cohorts, agreed endpoints and known standards before deployment.
Track predictions, interventions and outcomes forward—not only against historical records.
Clear data lineage, protocol versioning, access control and institutional review readiness.
Decision support, never prescription. Uncertainty and missingness remain visible.
Institutional pilot
We are looking for clinical directors, nephrology and radiology unit heads, and research partners who want assumptions on the table—not buried in a black box.
hello@kuviyam.ai